EULAR/LinkedIn
Dec 18, 2025, 13:16
New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR
EULAR – European Alliance of Associations for Rheumatology shared a post on LinkedIn:
“NEWS ALERT!
EULAR has developed a new score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS). A key step forward that promises to advance research and improve symptom tracking, both in clinical trials and everyday practice.
Read the full EULAR Press Release here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 14, 2026, 16:17Jen Atkinson: Vine Reproductive Is Officially Open in Tulsa
-
Oct 14, 2026, 16:14Amy Mortimer: Officially 6 Months at Care Fertility
-
Oct 14, 2026, 16:11Devyanshi Dixit: Welcoming Marelda Rodrigues as a Speaker at the GFWH 2026
-
Oct 14, 2026, 16:08Deirdre O’Neill: How Far We’ve Gone to Get Women’s Health Heard
-
Oct 14, 2026, 16:06Final Call to Contribute to the Scientific Programme of the ESHRE 2028 Annual Meeting
-
Oct 14, 2026, 15:25Beyond Embryo Morphology: Can 2 Embryos Influence Each Other’s Implantation Through Endometrial Crosstalk?
-
Oct 14, 2026, 15:01Nitiz Murdia: 5,000 Indian Rupees and a 2-Room Fertility Clinic in 1988…
-
Oct 14, 2026, 14:58Devyanshi Dixit։ Can We Measure Ovarian Age?
-
Oct 14, 2026, 14:56Rohit Gutgutia: The IVF Price War, and Who Really Pays for It